Fight CRC Clinical Trial Finder
| NCT ID | Title | Phase | Date Added | Location | Prior IO Allowed | CRC-directed | Status | Drugs | Tags |
|---|---|---|---|---|---|---|---|---|---|
| NCT ID NCT03096093 |
TitleInvestigation of a Therapeutic Vaccine (ACIT-1) in Cancer | Phase
Phase 1, Phase 2
|
Date Added 2017-03-30 |
Location
United Kingdom
|
Prior IO Allowed Yes |
CRC-directed No |
Status
Active, not recruiting
|
Drugs
ACIT-1 |
Tags
MSS/ MMRp
|
| NCT ID NCT04130854 |
TitleINNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer | Phase
Phase 2
|
Date Added 2019-10-18 |
Location
Arizona, United States
North Carolina, United States Oregon, United States Texas, United States |
Prior IO Allowed No |
CRC-directed Yes |
Status
Active, not recruiting
|
Drugs
APX005M, mFOLFOX, and Radiation Therapy 5Gy x 5 days, mFOLFOX and Radiation Therapy 5Gy x 5 days |
Tags
MSS/ MMRp
|
| NCT ID NCT05611034 |
TitleIn Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung | Phase
Phase 1
|
Date Added 2022-11-09 |
Location
Canada
|
Prior IO Allowed Yes |
CRC-directed Yes |
Status
Recruiting
|
Drugs
oxaliplatin |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT05299840 |
TitleImpact of Using the Oncogramme(R) Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer | Phase
Not Applicable
|
Date Added 2022-03-29 |
Location
France
|
Prior IO Allowed No |
CRC-directed Yes |
Status
Recruiting
|
Drugs |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT01174121 |
TitleImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer | Phase
Phase 2
|
Date Added 2010-08-03 |
Location
Maryland, United States
|
Prior IO Allowed Yes |
CRC-directed Yes |
Status
Recruiting
|
Drugs
Aldesleukin, Cyclophosphamide, Fludarabine, Pembrolizumab (Keytruda), Young TIL |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT04444622 |
TitleImmunotherapy for Third Line Metastatic Colorectal Cancer | Phase
Phase 2
|
Date Added 2020-06-23 |
Location
Florida, United States
Michigan, United States New Jersey, United States New York, United States |
Prior IO Allowed No |
CRC-directed Yes |
Status
Active, not recruiting
|
Drugs |
Tags
MSS/ MMRp
|
| NCT ID NCT03658785 |
TitleImmunotherapy for the Treatment of Advanced Solid Tumor | Phase
Phase 1
|
Date Added 2018-09-05 |
Location
China
|
Prior IO Allowed Yes |
CRC-directed No |
Status
Recruiting
|
Drugs
Aldesleukin, Cyclophosphamide, Fludarabine, TIL |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT06515314 |
TitleHRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors | Phase
Phase 1
|
Date Added 2024-07-23 |
Location
China
|
Prior IO Allowed Yes |
CRC-directed No |
Status
Recruiting
|
Drugs |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT03366155 |
TitleHepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver | Phase
Phase 2
|
Date Added 2017-12-08 |
Location
Maryland, United States
|
Prior IO Allowed No |
CRC-directed Yes |
Status
Active, not recruiting
|
Drugs
5FU, cetuximab, FUDR-Dex, Irinotecan, Medtronic SynchroMed II Pump with Codman 3000 Constant Flow Pump Catheter, OneRNA, oxaliplatin, panitumumab |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT06558773 |
TitleGSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC. | Phase
Phase 2
|
Date Added 2024-08-19 |
Location
China
|
Prior IO Allowed Yes |
CRC-directed Yes |
Status
Not yet recruiting
|
Drugs |
Tags
MSS/ MMRp
|
